Overview of Dendritic-Cell Cancer Vaccines

An article from nj.com looks over the past decade of research and trials in a particular -- and very promising -- class of cancer vaccine. I've said before here that cancer is no longer a grave threat to life in developed countries. The end result of decades of well-publicized research and high levels of funding has finally come: numerous effective therapies are about to arrive in the market. This success story can be repeated for anti-aging research and regenerative medicine, but only if we manage to make these fields as popular and as well funded. Activism and advocacy are very important.

Link: http://www.nj.com/newsflash/business/index.ssf?/cgi-free/getstory_ssf.cgi?f0061_BC_WSJ--CancerResearch&&news&newsflash-financial

Comments

Post a comment; thoughtful, considered opinions are valued. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.